NCT00116441View on ClinicalTrials.gov

Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2000

Study Completion Date

October 31, 2004

Conditions
Multiple Myeloma
Interventions
BIOLOGICAL

Therapeutic Cellular Vaccine, GM-CSF Producing

Trial Locations (1)

21231

Johns Hopkins University, Baltimore

Sponsors

Lead Sponsor

Cell Genesys
All Listed Sponsors
lead

Cell Genesys

INDUSTRY

NCT00116441 - Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma | Biotech Hunter | Biotech Hunter